Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Knee aspiration and intra-articular Depo-Medrol in inflammatory arthritis
ACTRN12608000127303Phase 4Not yet recruiting
- Sponsor
- Auckland University of Technology
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylprednisolone in arthritis, sponsored by Auckland University of Technology. Primary endpoints: Quadriceps muscle function, Lower limb function and 1 more. Planned start Jun 2008; status: not yet recruiting.
02
Drugs
methylprednisolone
03
Conditions
arthritis
Beyond the preview
Go deeper on ACTRN12608000127303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000127303.